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“ it’s technology married with liberal arts, married with the humanities, that yields us 
the results that make our heart sing” 
Steve Jobs 
 
The field of electrophysiology has long encompassed multiple different strands of science 
and industry in an attempt to yield better results for our patients. While subspecialisation of 
electrophysiology and electrophysiologists continues at a pace, at the same time our 
interdependence on others increases. Managing patients with atrial fibrillation (AF) often 
requires multiple specialists to assess and treat the co-morbidities that our patients have, 
while when considering who and how to ablate our patients we are increasing using ever 
more complex imaging and mapping systems. In almost twenty years from the initial 
description of pulmonary vein isolation, and the acceptance that this is the cornerstone of 
AF ablation we are still unable to consistently achieve this apparently simple task. In this 
issue of The Journal, Taghji et al (1) present their work which will potentially revolutionise 
the care of patients with AF and also our understanding of it by demonstrating how to 
achieve permanent pulmonary vein isolation safely and reliably.  
Contact force has unsurprisingly long been known as an important factor in lesion creation 
(2). Similarly a drop in impedence during ablation is also a known marker of lesion creation 
(3, 4). While it took a while for catheters to be developed that were able to measure the 
degree of contact at the catheter tip, their use in cases is now ubiquitous. However, 
although it is perhaps obvious that procedures are better when the operator has the 
availability of contact force data, the trials have not supported this view (Table 1). If we 
explore the available data in more detail it is perhaps not that surprising. Until recently 
there has been little histological correlation between force and lesion creation and lesion 
transmurality (5), which has perhaps given rise to the wide variation in contact force values 
used in trials. Similarly, although preclinical work on lesion creation has been performed this 
is rarely done in the atria (6). Ablation of the thin walled atrium is clearly different from 
ablation in the thicker walled ventricle or canine thigh preparation model. While data 
apparently demonstrating the accuracy of indices of ablation has been performed, an 
accuracy of ±1mm is clearly different when ablating the atrial wall which can be 1-2mm 
compared to the ventricle (6). The problem with all current technologies is that tissue 
thickness is not taken into account (7). While this is clearly an important variable, and tissue 
thickness varies widely, only ultrasound so far has been used to measure this during 
ablation (8).  
In this issue of the journal Taghji et al (1) present work on a series of 130 patients 
undergoing first time ablation for paroxysmal AF. Using objective measures of lesion 
creation (ablation Index, AI) and importantly objectively measuring and keeping within a 
maximal interlesion distance of 6mm, they demonstrated both a high rate of acute 1st pass 
pulmonary vein isolation and more importantly, that by using these objective measures a 
very high level of clinical success at 1 year following the ablation. This work was made 
possible by a thorough understanding of the biophysics of radiofrequency, application of 
technology at the catheter tip and displaying the complex information to the end user. A 
true intersection of a number of different skills.  Other markers of lesion creation, such as 
impedence drop (Median drop 12.7 Ohms) were consistent with good quality lesions. The 1 
year success rate is remarkable, with a 91% freedom from AF in all patients. What is perhaps 
even more interesting is in the patients that had to return for a second ablation, only 1 of 
the 10 patients had reconnection of the pulmonary veins that could not be explained by low 
AI or poor lesion contiguity. 
While the success of the procedure using these parameters is excellent, this is still a work in 
progress, and can be refined. The values for AI, while based on some pre-clinical and clinical 
work, are arbitrary. It is notable that in 40% of the cases the lesions on the posterior wall did 
not meet the pre-defined criteria of an AI of 400 due to a rise in oesophageal temperature. 
Despite this AF was adequately treated for these patients. It is almost certainly the case that 
the values used for AI are more than what is required. While finessing of the AI values will 
likely be attempted in similar studies, perhaps it is time to take a different approach to such 
questions. In many fields, both within medicine and outside medicine, big data approaches 
have paid dividends (9, 10). While significant regulatory hurdles exist to sharing personal 
data the potential benefits to understanding how to utilise AI and having a “correct” target 
number, as opposed to something divisible by 10, should outweigh our prejudices. 
Additionally, although the complication rate from AF ablation is low in most reported 
studies, especially for atrial oesophageal fistula, it is probable that more energy is being 
delivered than is absolutely necessary, rendering the necessity for assessment of tissue 
thickness less of an issue. However, with widespread use of ablation index it is likely that 
some patients will unfortunately have this complication. Individual case reports will not help 
us understand this, but national or international registries and big data approaches could be 
helpful. 
This study focused on patients with paroxysmal AF, as is right when trying a new approach, 
to have as homogenous population as possible. Clearly though knowing that we really can 
do what we are attempting to achieve will help us understand persistent AF more than at 
present. Following the STAR AF II data, strategies that involve more than just pulmonary 
vein isolation have come under closer scrutiny. While we have been unable to reliably 
achieve permanent block across linear lesions, or reliably isolate the posterior wall, it is 
difficult to fully understand whether the failure is due to the strategy or the deployment of 
lesions. The use of the algorithm presented may allow us to answer these questions once 
and for all. When there is certainty about the outcome, novel lesion sets may be used. For 
example, complete isolation of the posterior wall and pulmonary veins can be achieved with 
one contiguous lesion set, “the big box” Figure 1.  
Finally, is it time to re-examine the blanking period? With health systems under financial 
pressure a shorter duration of follow up is preferable for many reasons. Currently given the 
relatively high rate of recurrence, follow up periods for at least a year are commonplace. 
However, if the results of this study are replicated in real world practice and future studies 
reproduce these data it may be that absence of arrhythmia within the blanking period will 
portend a good clinical result from ablation.  
Just as Apple were not the first to introduce a portable digital music player with the iPod, or 
the first to introduce a phone to connect to the internet, the concept of good quality 
contiguous lesions to achieve permanent pulmonary vein isolation is neither new nor novel. 
However, the elegant execution of these tasks will likely revolutionise the treatment of 
patients with atrial fibrillation, just as the iPod and iPhone revolutionised their respective 
markets. 
  
  
Figure 1. “Big Box” isolation. In this patient the entire posterior wall was isolated with one 
set of contiguous lesions with an ablation index of 400 and an interlesion distance <6mm. 
On completion of the box the posterior wall and veins were isolated. This strategy minimises 
the amount of ablation on the posterior wall compared to separet lesion sets to isolate the 
veins and then isolate the posterior wall.  
 Table 1. Trials of Contact Force  
 
Study Patient 
Population 
Contact force 
range 
Strategy Outcome 
Toccastar (11) Paroxysmal AF, 
300 patients 
No target range 
specified 
Pulmonary vein 
isolation only 
No difference in 
primary 
outcome vs. 
non contact 
force (67.8% 
Contact force 
group) 
Smart AF (12) Paroxysmal AF, 
160 patients 
No target range 
specified 
Multiple 
strategies 
employed 
74% 1 year 
arrhythmia free 
survival 
UK Multicentre 
Trial Group(13) 
Paroxysmal AF, 
117 patients 
5-40g Pulmonary vein 
isolation only 
49% 1 year 
success rate, no 
difference 
between groups 
Touch AF (14) Persistent AF, 
160 patients 
10-20g PV antral 
ablation and 
roof line 
61% 1 year 
arrhythmia free 
survival; no 
difference 
between groups 
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